Startup data
| Business model | |
|---|---|
| Country | |
| Investment Received | |
| Revenues | |
| Scope | |
| Startup stage | |
| Tecnhologies | |
| Verticals |
COBIOMIC Bioscience
€0,00
Video-Pitch: https://cobiomic.com/wp-content/uploads/2021/10/WhatsApp-Video-2021-10-20-at-4.38.25-PM.mp4
Description: Biotech spin-off of University of Cordoba (EBT-UCO) and IMIBIC. The R&D line focuses on predicting responders vs non-reponders to biologics, in patients suffering from rhuematic diseases. The aim of this project is to develop a test that will combine a blood analysis, clinical information and bioinformatics by developing a Diagnostic test that identifies the ‘non-responders’ before start of therapy. COBIOMIC is also the first core-lab of Olink (OLK – NASDAQ) providing high-throughput proteomic analysis (protein biomarkers) using qPCR on 1ul of any biological sample type. Boosting personalised medicine in various disease areas.
Web: http://cobiomic.com
